[November 17, 2017 450 Fifth Street, NW We have read the statement as it related to our firm being made by Lianluo Smart Limited in its Form 6-K dated November 17, 2017. We have no basis to agree or disagree with the other statements contained therein. Forest Hills, New York] []
[PETROCHINA COMPANY LIMITED (a joint stock limited company incorporated in the Peoples Republic of China with limited liability) (Stock Code: 857) ANNOUNCEMENT REGARDING THE APPROVAL OF THE PROPOSED ISSUANCE OF EXCHANGEABLE CORPORATE BONDS BY THE CONTROLLING SHAREHOLDER Company CNPC Proposed Exchang]
[UTStarcom Reports Unaudited Financial Results for the Third Quarter of 2017 Hong Kong, November 20, 2017 UTStarcom (UTStarcom or the Company) (NASDAQ: UTSI), a global telecommunications infrastructure provider, today reported its unaudited financial results for the third quarter ended September]
[The merger, which is currently expected to close during the first quarter of 2018, is subject to customary closing conditions including the approval of the Merger Agreement by the affirmative vote of holders of Shares representing at least two-thirds of the voting power of the Shares present and vot]
[Xinyuan Real Estate Co., Ltd. to Hold Annual General Meeting of Shareholders on December 15, 2017 BEIJING, November 20, 2017 About Xinyuan Real Estate Co., Ltd. Xinyuan Xinyuan Real Estate Co., Ltd. (“ For more information, please contact: Xinyuan Real Estate Co., Ltd. Mr. Joe Xu Investor Relations ]
[XUNLEI ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2017 Shenzhen, China, November 16, 2017 (GLOBE NEWSWIRE) – Xunlei Limited (“Xunlei” or the “Company”) (Nasdaq: XNET), a leading cloud-based acceleration technology company in China, today announced its unaudited f]
[China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2018 2Q18 Added 23,647 New Subscribers 2Q18 Revenues Up 27.4% YOY to RMB234.6 Million ($35.3 Million) 2Q18 Operating Income Up 39.4% YOY to RMB76.3 Million ($11.5 Million) Conference Call to be Hel]
[FORM 10-Q (Mark One) ☒ September 30, 2017 For the quarterly period ended: Or ☐ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Nu]
[FORM 10−Q (Mark One) [X] September 30, 2017 For the quarterly period ended: [ ] For the transition period from _____________ to _____________ 001-32898 CBAK ENERGY TECHNOLOGY, INC. Nevada 88-0442833 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) B]
[SHARE PURCHASE AGREEMENT THIS SHARE PURCHASE AGREEMENT Agreement Company Buyer Parties Party WHEREAS: 1933 Act Regulation D SEC Ordinary Shares Shares B. The Buyer wishes to purchase, and the Company wishes to sell, upon the terms and conditions stated in this Agreement, 3,000,000 ordinary shares of]
